Biotransformations of rifamycins: process possibilities.

Banerjee, U C and Saxena, B and Chisti, Y. (1992) Biotransformations of rifamycins: process possibilities. Biotechnology advances, 10 (4). pp. 577-95. ISSN 0734-9750

PDF banerjee92.pdf - Published Version Restricted to Registered users only Download (766Kb) | Request a copy

Abstract

Rifampicin, an important antibiotic, is manufactured by chemical conversion of rifamycin S which is obtained by the chemical modification of rifamycin B. Rifamycin B is a product of Nocardia mediterranei fermentations. The chemical conversion of rifamycin B to rifamycin S has many disadvantages: Strong acidic conditions are required, heavy foam formation accompanies transformation and the yields are low. This review highlights the developments in alternative, biochemical transformations using enzymes and cells; the main focus is on transformations carried out by rifamycin oxidase.

Item Type:	Article
Additional Information:	Copyright of this article belongs to Elsevier Science
Subjects:	Q Science > QD Chemistry
Depositing User:	Dr. K.P.S.Sengar
Date Deposited:	12 Dec 2011 15:38
Last Modified:	29 Mar 2012 06:48
URI:	http://crdd.osdd.net/open/id/eprint/425

Actions (login required)

View Item